PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tests show new biosensor can guide environmental clean-ups

Device can also provide an early warning system for spills

2011-05-08
(Press-News.org) Tests of a new antibody-based "biosensor" developed by researchers at the Virginia Institute of Marine Science show that it can detect marine pollutants like oil much faster and more cheaply than current technologies. The device is small and sturdy enough to be used from a boat.

Testing of the biosensor in the Elizabeth River and Yorktown Creek, which both drain into lower Chesapeake Bay, shows that the instrument can process samples in less than 10 minutes, detect pollutants at levels as low as just a few parts per billion, and do so at a cost of just pennies per sample. Current technology requires hours of lab work, with a per-sample cost of up to $1,000.

"Our biosensor combines the power of the immune system with the sensitivity of cutting-edge electronics," says Dr. Mike Unger of VIMS. "It holds great promise for real-time detection and monitoring of oil spills and other releases of contaminants into the marine environment."

The biosensor was developed and tested by Unger, fellow VIMS professor Steve Kaattari, and their doctoral student Candace Spier, with assistance from marine scientist George Vadas. The team's report of field tests with the sensor appears in this month's issue of Environmental Toxicology and Chemistry.

The instrument was developed in conjunction with Sapidyne Instruments, Inc., with funding from the state of Virginia, the Office of Naval Research, and the Cooperative Institute for Coastal and Estuarine Environmental Technology, a partnership between NOAA and the University of New Hampshire.

The tests in the Elizabeth River took place during clean up of a site contaminated by polycyclic aromatic hydrocarbons (PAHs), byproducts of decades of industrial use of creosote to treat marine pilings. The U.S. Environmental Protection Agency considers PAHs highly toxic and lists 17 as suspected carcinogens.

The biosensor allowed the researchers to quantify PAH concentrations while the Elizabeth River remediation was taking place, gaining on-site knowledge about water quality surrounding the remediation site. Spier says the test was "the first use of an antibody-based biosensor to guide sampling efforts through near real-time evaluation of environmental contamination."

In the Yorktown Creek study, the researchers used the biosensor to track the runoff of PAHs from roadways and soils during a rainstorm.

Biosensor development

Kaattari says "Our basic idea was to fuse two different kinds of technologies—monoclonal antibodies and electronic sensors—in order to detect contaminants."

Antibodies are proteins produced by the immune system of humans and other mammals. They are particularly well suited for detecting contaminants because they have, as Kaattari puts it, an "almost an infinite power to recognize the 3-dimensional shape of any molecule."

Mammals produce antibodies that recognize and bind with large organic molecules such as proteins or with viruses. The VIMS team took this process one step further, linking proteins to PAHs and other contaminants, then exposing mice to these paired compounds in a manner very similar to a regular vaccination.

"Just like you get vaccinated against the flu, we in essence are vaccinating our mice against contaminants," says Kaattari. "The mouse's lymphatic system then produces antibodies to PAHs, TNT, tributyl tin [TBT, the active ingredient in anti-fouling paints for boats], or other compounds."

Once a mouse has produced an antibody to a particular contaminant, the VIMS team applies standard clinical techniques to produce "monoclonal antibodies" in sufficiently large quantities for use in a biosensor.

"This technology allows you to immortalize a lymphocyte that produces only a very specific antibody," says Kaattari. "You grow the lymphocytes in culture and can produce large quantities of antibodies within a couple of weeks. You can preserve the antibody-producing lymphocyte forever, which means you don't have to go to a new animal every time you need to produce new antibodies."

From antibody to electrical signal

The team's next step was to develop a sensor that can recognize when an antibody binds with a contaminant and translate that recognition into an electrical signal. The Sapidyne® sensor used by the VIMS team works via what Kaattari calls a "fluorescence-inhibitory, spectroscopic kind of assay."

In the sensor used on the Elizabeth River and Yorktown Creek, antibodies designed to recognize a specific class of PAHs were joined with a dye that glows when exposed to fluorescent light. The intensity of that light is in turn recorded as a voltage. The sensor also houses tiny plastic beads that are coated with what Spier calls a "PAH surrogate"—a PAH derivative that retains the shape that the antibody recognizes as a PAH molecule.

When water samples with low PAH levels are added to the sensor chamber (which is already flooded with a solution of anti-PAH antibodies), the antibodies have little to bind with and are thus free to attach to the surrogate-coated beads, providing a strong fluorescent glow and electric signal. In water samples with high PAH concentrations, on the other hand, a large fraction of the antibodies bind with the environmental contaminants. That leaves fewer to attach to the surrogate-coated beads, which consequently provides a fainter glow and a weaker electric signal.

During the Elizabeth River study, the biosensor measured PAH concentrations that ranged from 0.3 to 3.2 parts per billion, with higher PAH levels closer to the dredge site. In Yorktown Creek, the biosensor showed that PAH levels in runoff peaked 1 to 2 hours after the rain started, with peak concentration of 4.4 parts per billion.

Comparison of the biosensor's field readings with later readings from a mass spectrometer at VIMS showed that the biosensor is just as accurate as the more expensive, slower, and laboratory-bound machine.

A valuable field tool

Spier says "Using the biosensor allowed us to quickly survey an area of almost 22 acres around the Elizabeth River dredge, and to provide information about the size and intensity of the contaminant plume to engineers monitoring the dredging from shore. If our results had shown elevated concentrations, they could have halted dredging and put remedial actions in place."

Unger adds "measuring data in real-time also allowed us to guide the collection of large-volume water samples right from the boat. We used these samples for later analysis of specific PAH compounds in the lab. This saved time, effort, and money by keeping us from having to analyze samples that might contain PAHs at levels below our detection limit."

"Biosensors have their constraints and optimal operating conditions," says Kaattari, "but their promise far outweighs any limitations. The primary advantages of our biosensor are its sensitivity, speed, and portability. These instruments are sure to have a myriad of uses in future environmental monitoring and management."

One promising use of the biosensor is for early detection and tracking of oil spills. "If biosensors were placed near an oil facility and there was a spill, we would know immediately," says Kaattari. "And because we could see concentrations increasing or decreasing in a certain pattern, we could also monitor the dispersal over real time."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Dr. Knight Offers Interactive Where Does it Hurt Online Tool

2011-05-08
The Hand and Wrist Institute, the leading hand specialist experts in the State of California now offers a "Where Does It Hurt" tool on their website, www.handandwristinstitute.com. The Hand and Wrist Institute is a medical center that focuses primarily on the surgery of hands and wrists. This institute is backed by Dr. John T. Knight, one of the top medical experts in the field of hand and wrist surgery. Dr. John T. Knight is a board certified Orthopedic Surgeon who oversees the operations of the Hand and Wrist Institute at DISC to ensure that all of their ...

New technology helps to find gene responsible for Kufs disease

New technology helps to find gene responsible for Kufs disease
2011-05-08
Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy. Dr Melanie Bahlo, Ms Katherine Smith and Ms Catherine Bromhead from the Walter and Eliza Hall Institute's Bioinformatics division, in collaboration with neurologist and epilepsy specialist Professor Sam Berkovic and Dr Todor Arsov from the University of Melbourne, ...

PCH Treatment Treats Panic Disorder

PCH Treatment Treats Panic Disorder
2011-05-08
The Psychological Care and Healing Treatment Center, the leading destination for people who want to have their psychological disorders fixed, now offers Panic Disorder treatment Clinic. A Panic Disorder is considered as such when a person experiences several panic attacks within a short period of time. First of all, people must know that panic attacks are not very common. In fact, some people live their lives and experience only as little as two or three panic attacks through out their lives. This is why it is very uncommon to experience or suffer from several panic ...

Strong evidence supports prognostic value of circulating tumor cells in breast cancer

2011-05-08
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression. At the IMPAKT Breast Cancer Conference in Brussels, Dr François-Clement Bidard and colleagues from Institut Curie in Paris say their new findings set the scene for interventional trials designed to see if improved outcomes can be achieved by modifying treatment based on circulating tumor cell counts. "We needed to do this study to confirm data provided ...

Epigenetic study reveals new insights into breast cancer

2011-05-08
The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, Belgian researchers have reported. Epigenetics is a term used to describe modifications to the DNA molecule that affect way its code is translated into proteins. These changes include methylation, a form of chemical modification. Although researchers knew epigenetics was important in cancer, information about its exact contribution to breast carcinogenesis was scant, Dr Sarah Dedeurwaerder, from Université ...

Gene expression predicts chemotherapy sensitivity of triple-negative breast cancer

2011-05-08
German researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy. Triple-negative breast cancers --which do not express the genes for estrogen receptor, or progesterone receptor and do not have Her2/neu overexpression or amplification-- are more aggressive than other forms of the disease and cannot be treated with endocrine or Her2 targeted therapies. At the IMPAKT Breast Cancer Conference in Brussels, PhD student Carolin Huelsewig and Dr Cornelia Liedtke from Uniklinikum Muenster ...

Breast cancer multi-gene tests compared

2011-05-08
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows. In recent years, several genomic tests have been developed to provide prognostic information for breast cancer. Dr Catherine Kelly from Mater Misericordiae University Hospital, Dublin, Ireland, and colleagues in the USA examined the agreement in prediction results between two multi-gene assays ...

Protein snapshots reveal clues to breast cancer outcomes

2011-05-08
Measuring the transfer of tiny amounts of energy from one protein to another on breast cancer cells has given scientists a detailed view of molecular interactions that could help predict how breast cancer patients will respond to particular therapies. At the IMPAKT Breast Cancer Conference in Brussels, Dr Gargi Patel from the Richard Dimbleby Department, King's College London, described cutting-edge research in which she and colleagues captured detailed information about protein interactions on cancer cells, and correlated that with established genetic markers for cancer ...

Anti-inflammatory drug may fight breast cancer

2011-05-08
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels. The results of a randomized trial in 45 patients with primary invasive breast cancer showed that the drug --which is currently used to treat arthritis and other painful conditions-- clearly induced an anti-tumor response at the molecular level. "This is exciting because it means that a medication already used to treat other diseases may be efficient in the adjuvant treatment of breast cancer ...

Female-to-male transsexual people have more autistic traits

2011-05-08
Domenico Di Ceglie, Director of Training and Research at the Gender Identity Development Service at the Tavistock and Portman NHS Foundation Trust in London, commented: "These are important findings in the field of gender incongruence, which need to be replicated. The awareness of the presence of autistic features may help these young people to explore the reasons behind their perceptions, and help them make more informed decisions about treatment." Emma Martin, who runs a Gender Identity Support and research group in Little Downham, UK, welcomed the new findings, and ...

LAST 30 PRESS RELEASES:

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

Association of state cannabis legalization with cannabis use disorder and cannabis poisoning

Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

[Press-News.org] Tests show new biosensor can guide environmental clean-ups
Device can also provide an early warning system for spills